Deals
Boutique Firms Steal the Show on Year’s Top Health-Care Deal
- Astra’s lead advisers on $39 billion deal are both boutiques
- Evercore, Centerview move up league tables on Alexion takeover
Astra’s boutique-heavy lineup was reminiscent of the $40 billion sale of British chip designer Arm.
Photographer: Jason Alden/BloombergThis article is for subscribers only.
Boutique advisory firms are taking most of the limelight on the year’s biggest health-care deal.
AstraZeneca Plc tapped Evercore Inc. and Centerview Partners as lead financial advisers on its $39 billion takeover of Alexion Pharmaceuticals Inc. This deal helped Evercore jump three places higher in the mergers and acquisitions league tables, to No. 9 globally, while Centerview moved up five spots to No. 12, according to data compiled by Bloomberg.